Fortrea Holdings Inc. - Common Stock (NQ:FTRE)

25.88 +1.45 (+5.94%)

Delayed Quote Updated: 4:00 PM EDT, Oct 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Fortrea Holdings Inc. - Common Stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Expert Outlook: Fortrea Holdings Through The Eyes Of 5 Analysts ↗

January 25, 2024

Via Benzinga

Fortrea Establishes Industry Partnership with Veeva and Advarra to Streamline Patient and Site Clinical Trial Experience

January 09, 2024

Companies partner to provide patients and sites with easy access to study information in one integrated solution

From Fortrea Holdings Inc

Via GlobeNewswire

Fortrea Previews J.P. Morgan Healthcare Conference Updates

January 08, 2024

From Fortrea Holdings Inc

Via GlobeNewswire

Where Fortrea Holdings Stands With Analysts ↗

January 04, 2024

Via Benzinga

The Latest Analyst Ratings for Fortrea Holdings ↗

December 01, 2023

Via Benzinga

Why Fortrea Holdings Shares Are Gaining Today ↗

October 17, 2023

Activist hedge fund Starboard Value holds a

Via Benzinga

Fortrea to Present at the 42nd Annual J.P. Morgan Healthcare Conference

January 02, 2024

From Fortrea Holdings Inc

Via GlobeNewswire

Are November’s 3 Biggest Stock Losers Worth Snapping Up Now? ↗

December 17, 2023

The market was like an iceberg with only a few winners showing but that means there are a lot of the biggest stock losers worth getting now.

Via InvestorPlace

Fortrea Convenes New Site Advisory Board

December 13, 2023

Fortrea’s Site Advisory Board brings research leaders together to focus on evolving site, sponsor and patient relationships

From Fortrea Holdings Inc

Via GlobeNewswire

Why Is Inflammation Disease Focused Acelyrin Stock Trading Lower Today? ↗

November 28, 2023

Acelyrin Inc (NASDAQ: SLRN) updated its izokibep clinical development program, including its ongoing global Phase 2b/3 trial for izokibep in

Via Benzinga

Fortrea Announces AI-Driven Partnership with Medidata to Increase Diversity in Clinical Trials

November 20, 2023

Collaboration leverages Medidata AI to improve access and participation of diverse population groups in clinical studies

From Fortrea Holdings Inc

Via GlobeNewswire

Why Fortrea Holdings Stock Climbed Nearly 10% Higher Today ↗

November 13, 2023

The company's first quarter as a separate entity was better than anticipated.

Via The Motley Fool

Monday.Com Reports Q3 Beat, Joins Fortrea Holdings, Henry Schein And Other Big Stocks Moving Higher On Monday ↗

November 13, 2023

U.S. stocks traded lower, with the Dow Jones falling around 40 points on Monday.

Via Benzinga

Topics Stocks

Earnings Scheduled For November 13, 2023 ↗

November 13, 2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.

Via Benzinga

Fortrea Reports Third Quarter 2023 Results

November 13, 2023

From Fortrea Holdings Inc

Via GlobeNewswire

Fortrea Completes Expansion of Clinical Pharmacology Solutions Following Targeted Investments at its Four Clinical Research Units in U.S. and U.K.

November 02, 2023

Adds speed and agility with cGMP production at on-site pharmacies, adds capacity, improves flexible therapeutic capabilities and enhances experience for study volunteers

From Fortrea Holdings Inc

Via GlobeNewswire

Starboard Value Issues Presentation Delivered at 13D Monitor’s 2023 Active-Passive Investor Summit

October 17, 2023

From Starboard Value LP

Via Business Wire

Fortrea Appoints Life Science Executive Dr. John Doyle to Lead Consulting Team

October 13, 2023

Industry veteran brings more than three decades of experience spanning R&D, commercialization, and market access

From Fortrea Holdings Inc

Via GlobeNewswire

Fortrea Announces Date for Third Quarter 2023 Financial Results and Conference Call

October 11, 2023

From Fortrea Holdings Inc

Via GlobeNewswire

Fortrea’s Jim Cameli Named a Top 100 Global Chief Information Security Officer by HotTopics

October 10, 2023

From Fortrea Holdings Inc

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2023 ↗

September 14, 2023

Via Benzinga

Fortrea to Present at the Baird 2023 Global Healthcare Conference

September 06, 2023

From Fortrea Holdings Inc

Via GlobeNewswire

Fortrea to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

September 06, 2023

From Fortrea Holdings Inc

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2023 ↗

August 16, 2023

Via Benzinga

Why Fortrea Holdings Stock Is Sinking Today ↗

August 14, 2023

The contract research organization's first quarterly update as a stand-alone entity disappointed investors.

Via The Motley Fool

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 14, 2023

Via Benzinga

Fortrea Reports Second Quarter 2023 Results and Provides Full-Year 2023 Guidance

August 14, 2023

From Fortrea Holdings Inc

Via GlobeNewswire

Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

August 14, 2023

Gainers Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into definitive agreement to acquire the company for total potential consideration...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 7, 2023 ↗

August 07, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

August 04, 2023

On Friday, 73 companies reached new 52-week lows.

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.